Cargando…
Docking analysis and the possibility of prediction efficacy for an anti-IL-13 biopharmaceutical treatment with tralokinumab and lebrikizumab for bronchial asthma
Interleukin-13 (IL-13) is associated with allergic airway inflammation and airway remodeling. Our group found a variant with a single nucleotide polymorphism in the IL13 gene at position +2044G>A (rs20541) that was expected to result in the non-conservative replacement of a positively charged arg...
Autores principales: | Nakamura, Yutaka, Sugano, Aki, Ohta, Mika, Takaoka, Yutaka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5695818/ https://www.ncbi.nlm.nih.gov/pubmed/29155876 http://dx.doi.org/10.1371/journal.pone.0188407 |
Ejemplares similares
-
Lebrikizumab in the personalized management of asthma
por: Thomson, Neil C, et al.
Publicado: (2012) -
Profile of lebrikizumab and its potential in the treatment of asthma
por: Maselli, Diego Jose, et al.
Publicado: (2015) -
Prediction of infectivity of SARS-CoV2: Mathematical model with analysis of docking simulation for spike proteins and angiotensin-converting enzyme 2
por: Takaoka, Yutaka, et al.
Publicado: (2022) -
Binding, Neutralization and Internalization of the Interleukin-13 Antibody, Lebrikizumab
por: Okragly, Angela J., et al.
Publicado: (2023) -
Efficacy of femtosecond lasers for application of acupuncture therapy
por: Ohta, Mika, et al.
Publicado: (2016)